home · stocks; RLFTF OTC. Relief Therapeutics Holding AG. RLFTF (OOTC). 0.31. -0.02 (-5.92%). i:usd•Från och med: 06 apr. 2021 15:59 UTC -4•Marknad:

Get the latest RELIEF THERAPEUTICS Holding SA (RLFTF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

April 4, 2021 April 12, 2021 Michael Spencer Comment. As the Third Wave begins to deciminate South America, Europe, India and even parts of North America, what is the future of our Become a Futurist. 2020-08-29 Stock analysis for Relief Therapeutics Holding AG (RLF:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2020-07-28 RLFTF currently has no news.

the stock is 65.5% away from all-time highs of $0.95: rlftf is up 6% since the beginning of the year: rlftf is up 1196% over the past 12 months: rlftf is down -2% over the past 1 month: n/a% of all rlftf investors are betting against rlftf: num investors short rlftf has gone up n/a% versus last month 2020-08-02 2021-04-05 2019-01-01 Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Relief Therapeutics Holding AG - RLFTF Stock Chart Technical Analysis for 08-04-2020 Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/ F RLFTF Stock Quote. Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield. 1 day 5 days 10 days 1 month 3 months 6 months 1 year » Buy RLFTF Online Today!, find the best broker here. Bitcoin & Crypto Movers .

© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved.

Relief Therapeutics Holding AG (RLFTF) stock price prediction is 1.632869 USD. The Relief Therapeutics Holding AG stock forecast is 1.632869 USD for 2022 April 22, Friday; and 14.693 USD for 2026 April 22, Wednesday with technical analysis.

9.01%. Price. Price. 0.30%.

View live RELIEF THERAPEUTICS HOLDING AG chart to track its stock's price action. Find market predictions, RLFTF financials and market news.

2021-04-06 · Relief Therapeutics (Relief Therapeutics: RLFTF) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings Huge Spec play What's it worth?

Relief Therapeutics (RLFTF) could survive that nightmare by growing 0.49% and riding over fifty-cent while many OTC stocks dream about that position. RLFTF Stock Quote. Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield. 1 day 5 days 10 days 1 Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. On PennyStocks.com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles.
Tina tina

Relief Therapeutics (RLFTF) could survive that nightmare by growing 0.49% and riding over fifty-cent while many OTC stocks dream about that position. RLFTF Stock Quote.

Price. Price.
Marika carlsson stand up

uddevalla skola
anders landgren enköping
aneby kommun schoolsoft
selma lagerlöf svenska akademien
stockholm handbollförbund resultat
schoolsoft värmdö inloggning

A stock market is used for the trading of shares of company stock. Find out how the stock market works and learn about the stock trading process. Advertisement By: Marshall Brain & Dave Roos For a new investor, the stock market can feel a l

Relief Therapeutics Holding AG quote is equal to 0.277 USD at 2021-04-18. Based on our forecasts, a long-term increase is expected, the "RLFTF" stock price prognosis for 2026-04-08 is 1.962 USD. RLFTF Stock Risk This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0270 between high and low, or 10.36%. For the last week, the stock has had a daily average volatility of 8.48%. RLFTF - the most promising COVID-19 Stock / Drug?